Contact
 

Update on Future Conferences - April 23, 2012

The Secretariat of the Global HIV Vaccine Enterprise provided an update on future AIDS Vaccine conferences.  In the update to stakeholders, Bill Snow  noted that recent breakthroughs in vaccines and other HIV prevention technologies...

Congratulations to Jose Esparza, who received the prestigious Congressional Medal of Merit on 19 April in recognition of his distinguished contributions to global health.  

The Global HIV Vaccine Enterprise Board of Directors appointed Bill Snow to serve as Director of its Secretariat.  Bill has a long and distinguished history in the HIV vaccine field and knows the history of the Enterprise well, having...

AIDS Vaccine 2012 is accepting applications for satellite sessions, click here for more information.  And do not forget to submit your abstracts and...

AIDS Vaccine 2012 is accepting abstract submissions and scholarship applications through 6 April 2012.  Visit the conference web site for more information and to submit your applications,...

The OCTAVE Project, the South African MRC, HVTN and SCHARP are soliciting applications for a workshop  for YECIs on key statistical considerations for the design and analysis of HIV vaccine trials. Click the PDF below for more details.

...

Join us for AIDS Vaccine 2012 in Boston, 9 - 12 September 2012.  For additional details, visit www.vaccineenterprise.org/conference/2012.

The Enterprise Board has begun recruiting qualified candidates to serve as Director of the Enterprise Secretariat; the job posting can be found on the Enterprise web site at http://www....

The AIDS Vaccine 2011 conference was attended by more than 820 researchers, representing 45 countries, and among the highlights was the exciting discussion around the results of the two-year case-controlled studies of RV144.  

New vaccine research suggests that scientists are homing in on the critical ingredients of a protective HIV vaccine and identifies new HIV vaccine candidates to test in human clinical trials....

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account